Ponsegromab - CAS 2368950-15-4

Ponsegromab (PF 06946860) is a selective and effective humanized anti-GDF15 antibody inhibitor with anti-cachexic activity. It binds to GDF15, preventing its interaction with GFRAL and disrupting GDF15/GFRAL mediated signaling. Ponsegromab has potential anticancer activity and can be used to treat cancer patients with cancer anorexia cachexia syndrome.

TGF-beta/Smad

Stem Cells

2368931

1

-20°C

Ice Packs

Inhibitory Antibodies